PIQ proteomics international laboratories ltd

Ann: Appendix 4C and Quarterly Report - March 2020, page-8

  1. 60 Posts.
    lightbulb Created with Sketch. 77
    Agreed! From the outside in, it looks like they’re running the a university science department. From a financial perspective though, PIQ has a lot operating leverage (ie fixed cost base) so incremental revenue gains will see this company reach profitably quickly and grow the earnings exponentially from there (presumably almost 100% gross margin on PromarkerD royalties). Rough numbers, but ~$4m annual cost base, $1.5m in revenue (exc R&D incentive). $2.5m in additional revenue will get it to breakeven.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.5¢
Change
-0.020(6.15%)
Mkt cap ! $49.87M
Open High Low Value Volume
33.5¢ 34.5¢ 28.5¢ $201.7K 642.4K

Buyers (Bids)

No. Vol. Price($)
1 3253 30.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 57411 2
View Market Depth
Last trade - 16.10pm 25/06/2025 (20 minute delay) ?
PIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.